Amphetamine-type stimulant use among patients admitted to the emergency department behavioural assessment unit: Screening and referral outcomes
- PMID: 32141682
- DOI: 10.1111/inm.12710
Amphetamine-type stimulant use among patients admitted to the emergency department behavioural assessment unit: Screening and referral outcomes
Abstract
Amphetamine-type stimulant use, including methamphetamine, amphetamine, and 3,4-methylenedioxymethamphetamine, is associated with a range of behavioural symptoms. Screening for amphetamine-type stimulant use among people presenting to the emergency department with behavioural disturbance and referral to treatment has not been evaluated. The objective of this study was to determine the prevalence of amphetamine-type stimulant use among patients admitted to a behavioural assessment unit and report referral outcomes. A prospective observational design was used. Individuals who tested positive or self-reported amphetamine-type stimulant use were referred to the alcohol and other drug clinician. We measured the prevalence of amphetamine-type stimulant use in saliva and by self-report along with rates of referral. The setting was a behavioural assessment unit located within an Australian emergency department. Admitted adults were enrolled from July to December 2017. Those who tested positive or self-reported amphetamine-type stimulant use were provided with harm reduction advice and offered referral. Four hundred and seventy-two tests were performed. Fifteen were excluded due to invalid results or redundant enrolment. Of the 457 individuals, 59% were male, with a mean age of 35 years (SD 13). Fifty-three (11.6%, 95% CI: 8.9-15.0) tested positive for amphetamine-type stimulants. Of those with a negative test, 44 (9.6%, 95% CI: 7.3-12.7) self-reported amphetamine-type stimulant use in the previous 24 hours. The prevalence of amphetamine-type stimulant use was 21.2% (95% CI: 17.7-25.2). Most accepted referral to the alcohol and other drug clinician (85.6%, 95% CI 77.2-91.2). The emergency visit represents a window of opportunity for screening for amphetamine-type stimulant use and initiating referrals.
Keywords: amphetamine; central nervous system stimulants; emergency service; point-of-care testing; referral; saliva.
© 2020 Australian College of Mental Health Nurses Inc.
References
REFERENCES
-
- Alarcon Manchego, P., Knott, J., Graudins, A., Bartley, B. & Mitra, B. (2015). Management of mental health patients in Victorian emergency departments: A 10 year follow-up study. Emergency Medicine Australasia, 27, 529-536.
-
- Australasian College for Emergency Medicine (2000 (last revised July 2016)). Guidelines on the Implementation of the Australasian Triage Scale in Emergency Departments.
-
- Australasian College for Emergency Medicine (2015). Policy on Public Health, Document No P56 ed.: Australasian College for Emernecy Medicine.
-
- Australian Institute of Health and Welfare (2017). National Drug Strategy Household Survey 2016. In: Welfare, A. I. o. H. a. (Ed). (p. 69). Canberra.
-
- Babor, T., McRee, B., Kassebaum, P., Grimaldi, P., Ahmed, K. & Bray, J. (2007). Screening, breif intervention and referral to treatment (SBIRT): Towards and public health approach to management of substance abuse. Substance Abuse Treatment, Prevention, and Policy, 28, 7-30.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
